Evidence map›Paper›PMID 29520699›Full record

Observational studyClinical research in cardiology : official journal of the German Cardiac Society2018

Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.

Stefan Baumann, Nikos Werner, Karim Ibrahim, Ralf Westenfeld, Fadi Al-Rashid, Jan-Malte Sinning, Dirk Westermann, Andreas Schäfer, Konstantinos Karatolios, Timm Bauer and 2 more

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical research in cardiology : official journal of the German Cardiac Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cardioprotective Strategies After Ischemia-Reperfusion Injury.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Handling high-risk patients in the catheterization laboratory.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  12. Optimized patient selection in high-risk protected percutaneous coronary intervention.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  13. Article
  14. Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Article
  15. Article
  16. Mechanical circulatory support with Impella in percutaneous coronary intervention: current status.American heart journal plus : cardiology research and practice · 2021
    Review
  17. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  18. Article
  19. Article
  20. Complex PCI procedures: challenges for the interventional cardiologist.Clinical research in cardiology : official journal of the German Cardiac Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Stefan BaumannFirst Department of Medicine-Cardiology, Faculty of Medicine Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Nikos WernerDepartment of Internal Medicine II, Rheinische Friedrich-Wilhelms University, Bonn, Germany.
Karim IbrahimTechnische Universität Dresden, Heart Center Dresden, University Hospital Dresden, Dresden, Germany.
Ralf WestenfeldDivision of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.
Fadi Al-RashidThe Department of Cardiology and Vascular Medicine of the West-German Heart and Vascular Center Essen, Essen University Hospital, University Duisburg-Essen, Essen, Germany.
Jan-Malte SinningDepartment of Internal Medicine II, Rheinische Friedrich-Wilhelms University, Bonn, Germany.
Dirk WestermannDepartment of General and Interventional Cardiology, University Heart Centre Hamburg Eppendorf, Hamburg, Germany.
Andreas SchäferDepartment of Cardiology and Angiology, Hannover Medical School, Hanover, Germany.
Konstantinos KaratoliosDepartment of Internal Medicine-Cardiology, Philipps University of Marburg, Marburg, Germany.
Timm BauerDepartment of Cardiology, University Clinic Giessen, Giessen, Germany.
Tobias BecherFirst Department of Medicine-Cardiology, Faculty of Medicine Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Ibrahim AkinFirst Department of Medicine-Cardiology, Faculty of Medicine Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. ibrahim.akin@umm.de.
Heidelberg University · DEUniversity of Bonn · DEEssen University Hospital · DEHeinrich Heine University Düsseldorf · DEMedizinische Hochschule Hannover · DEPhilipps University of Marburg · DETechnische Universität Dresden · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPercutaneous coronary intervention (PCI) is an alternative strategy to coronary artery bypass grafting (CABG) in patients with high perioperative risk. The microaxial Impella

methodsThe study is an observational, retrospective multi-center registry. Patients from nine tertiary hospitals in Germany, who have undergone protected high-risk PCI, are included in the present study.

resultsA total of 154 patients (mean age 72.6-10.8 years, 75.3% male) were enrolled. The majority were at a high operative risk illustrated by a logistic EuroSCORE of 14.7-17.4. The initial SYNTAX score was 32.0-13.3, indicating very complex CAD and could be reduced to 14.1-14.3 (p < 0.0001) after PCI. The main reasons for protected PCI were complex coronary anatomy (70.8%), personal impression (56.5%), reduced ventricular ejection fraction (49.4%), comorbidities (47.4%), and surgical turndown (30.5%). Four patients (2.6%) experienced an intrahospital death.

conclusionsData from the study show that protected PCI is a safe and effective approach to revascularize high-risk patients with complex coronary anatomy and comorbidities.

Indexed as

Heart-Assist DevicesRegistriesAgedCoronary Artery DiseaseFemaleGermanyHumansMalePercutaneous Coronary InterventionProsthesis DesignRetrospective StudiesVentricular Function, LeftHeart-assist deviceHemodynamicsHigh-risk PCIImpellaMechanical support

Identifiers

PMID29520699
OpenAlexW2790035126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.